Weekly Rundown: Small-Cap Stocks with Key Catalysts (August 25-29)

This weekly summary highlights recent filings, significant news, and strategic updates from small-cap companies. Review the key developments we're monitoring for the week of August 25-29.

--

16th Annual Midwest IDEAS Investor Conference:

Monday–Tuesday, August 26–27, 2025

The following companies are scheduled to participate in this year’s conference at the InterContinental, Chicago, IL:

● RYAM ● BRLT ● ZVIA ● RSSS ● SGRP

Key Catalysts This Week:

● JAGX – Participating in the 2025 Animal Health Summit to support potential collaboration to expand Canalevia (crofelemer delayed-release tablets) from chemotherapy-induced diarrhea in dogs to general diarrhea in dogs. Summit: August 25–26, 2025, Kansas City, MO.

● STAI – Scheduled participation in the 66th Annual Institute of Nuclear Materials Management (INMM) Conference, August 24–28, 2025, Washington, D.C.

● JRSH – CFO Gilbert Lee to participate in A.G.P.'s Virtual Consumer Showcase, August 25, 2025, 2:00 p.m. ET.

● REKR – Showcasing intelligent transportation advancements at ITS World Congress, August 24–28, 2025, Atlanta, GA.

● LIDR – Participating in ITS World Congress 2025, Atlanta, GA, August 25–28, 2025.

● AGEN – Hosting virtual Stakeholder Briefing, August 27, 2025, 4:00 p.m. ET, featuring updates on Zydus partnership, botensilimab (BOT) and balstilimab (BAL) program, Phase 3 BATTMAN study, and immuno-oncology milestones.

● RBBN – Participating in Jefferies Semiconductor, IT Hardware & Comm Tech Summit, Chicago, IL, August 26–27, 2025.

● ARBE – Participating in Jefferies Semiconductor, IT Hardware & Communications Technology Conference, August 26, 2025, Chicago, IL; Evercore Semiconductor, IT Hardware & Networking Conference, August 27, 2025, Chicago, IL.

● SVCO – CEO Dr. Babak Taheri participating in Jefferies' Semis, IT Hardware & Comm Tech Summit, Chicago, August 26–27, 2025.

● GNS – Live Spaces call on X.com, August 26, 2025, 9:00 a.m. ET, to provide legal update and host Q&A regarding market manipulation and RICO lawsuits.

● DCGO – CFO Norm Rosenberg participating in 1x1 meetings and delivering presentation, August 26, 2025, 11:30 a.m. CT.

● OTLK – FDA PDUFA goal date for ONS-5010, August 27, 2025.

● BDSX – CAP TODAY / Thermo Fisher Scientific Webinar: FDA-approved rapid NGS solution for companion diagnostics and tumor profiling, August 27, 2025.

● FLUX – Webinar: “Electrifying Warehouse & GSE Operations: Lithium-Ion Transition,” August 27, 2025, 8:00 a.m. PT / 11:00 a.m. ET.

● VLN – Jefferies Semiconductor Conference, August 26, 2025; Evercore ISI Semi Conference, August 27, 2025, Chicago, IL.

● GRYP – Stockholder voting commenced for stock-for-stock merger with American Bitcoin; Special Meeting on August 27, 2025, 10:00 a.m. ET.

● DIBS – CEO and CFO presenting at Midwest IDEAS Investor Conference, August 27, 2025, Chicago, IL.

● KYTX – Following successful FDA end-of-Phase 2 meeting, KYSA-6 trial expanding to Phase 3 portion, enrolling ~60 patients; virtual KOL event August 28, 2025.

● TNYA – Abstract accepted for ESC Annual Meeting presentation (MyClimb pediatric study), August 29–September 1, 2025, Madrid, Spain.

● INVZ – Showcasing ITS solutions at ITS World Congress, August 24–29, 2025, Atlanta, GA, booths #604 & #606.

● SAFX – Ringing Nasdaq Opening Bell, August 25, 2025, MarketSite, Times Square, NYC.

● HTCR – OEM sales agreement with Silver Egg Technology launches August 25, 2025, enhancing digital marketing capabilities via AI-powered CMS platform.

● LTRN – RedChip live investor webinar showcasing AI-driven cancer drug discovery (RADR® platform), August 26, 2025, 4:15 p.m. ET.

● OSTX – FDA End of Phase 2 meeting for osteosarcoma Phase 2b trial, August 27, 2025.

● CAPS – Signed agreement to acquire Carolina Stone Products; closing targeted by August 22, 2025.

● GRNT – Declared quarterly dividend of $0.11/share; payable September 15, 2025, record date August 29, 2025.

● NWL – Declared quarterly dividend of $0.07/share; payable September 15, 2025, record date August 29, 2025.

● RGP – Approved cash dividend of $0.07/share; payable September 26, 2025, record date August 29, 2025.

● FCUV – Scheduled customer testing of automated SEC reporting software, August 30, 2025; technology roadshow launch planned.

● TROO – Subsidiary Giant Connection entered Sale & Purchase Agreement for 49% of BLUE POOL VENTURES LIMITED, target completion August 31, 2025.

● NLSP – General meeting of shareholders to approve Merger Agreement with Kadimastem, August 25, 2025.

● JCSE – Entered option to purchase industrial property; expected completion by August 31, 2025; initial deposit SGD369,650 (USD274,000).

● PTIX – Completed first dose injection for multiple-dose portion of Phase I PT00114 clinical trial; dosing expected to complete by end of August 2025.

● MDCX – Acquisition of Antev shares via securities exchange agreement; acquisition expected to close by end of August 2025, contingent on approvals and milestone achievements.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.